Intranasal Efudix reduces epistaxis in hereditary hemorrhagic telangiectasia

ConclusionUnilateral application of 5-FU on a nasal tampon diminished the severity and frequency of epistaxis in all HHT patients. This effect sustained up to three  months post-treatment, despite the fact that the contralateral side remained untreated. Subsequently, hemoglobin levels increased. Intranasal 5-FU is a promising entity for further research on epistaxis treatment in HHT patients.
Source: Angiogenesis - Category: Molecular Biology Source Type: research